<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34708421</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>18</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1097-4598</ISSN><JournalIssue CitedMedium="Internet"><Volume>65</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Muscle &amp; nerve</Title><ISOAbbreviation>Muscle Nerve</ISOAbbreviation></Journal><ArticleTitle>Demographics, clinical characteristics, and prognostic factors of amyotrophic lateral sclerosis in Midwest.</ArticleTitle><Pagination><StartPage>217</StartPage><EndPage>224</EndPage><MedlinePgn>217-224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/mus.27450</ELocationID><Abstract><AbstractText Label="INTRODUCTION/AIMS">The Midwest has the highest regional prevalence of self-reported amyotrophic lateral sclerosis (ALS) in the United States, but with limited epidemiological studies. We aimed to explore the characteristics of patients with ALS in the Midwest.</AbstractText><AbstractText Label="METHODS">This was a retrospective cohort study of participants with ALS deceased between January, 2010, and September, 2020, registered with the ALS Association Mid-America Chapter. Demographics and clinical variables included gender, race/ethnicity, military status, site of onset, interventions (gastrostomy, non-invasive ventilation, tracheostomy), and visits to ALS Association-registered clinics. Disease characteristics were compared to the National ALS Registry, and survival analysis was performed followed by sample augmentation with historical data to estimate survival with hypothetical censoring.</AbstractText><AbstractText Label="RESULTS">The database included 1447 participants with a mean age at diagnosis of 65.7&#x2009;&#xb1;&#x2009;11.9&#xa0;y (&gt;60&#x2009;y at diagnosis: 72%). The median survival from symptom onset was 28.0&#xa0;mo (95% confidence limit: 26.3, 29.7); sample augmentation increased this to 41.0&#xa0;mo (38.5, 43.5). Bulbar onset disease and older age at diagnosis were associated with shorter survival. Participants not followed in ALS-Association registered clinics were more frequently male, had familial onset and tracheostomy. Veterans (N&#xa0;=&#xa0;298) were older at diagnosis but had similar survival after adjustment for age.</AbstractText><AbstractText Label="DISCUSSIONS">Our cohort had an older age at onset and more frequent bulbar onset than the National ALS Registry, perhaps reflecting ascertainment biases in each registry. Prospective cohort studies with more clinical and functional data are needed to better characterize ALS in Midwest, veterans, and non-clinic populations, and to optimize care.</AbstractText><CopyrightInformation>&#xa9; 2021 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yamakawa</LastName><ForeName>Mai</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6474-8910</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dwyer</LastName><ForeName>Sally</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>The ALS Association Mid-America Chapter, Mission, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>University of Missouri, Health Management and Informatics, School of Medicine, Columbia, Missouri, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Statland</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-0790-5315</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>UL1 TR002366</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Muscle Nerve</MedlineTA><NlmUniqueID>7803146</NlmUniqueID><ISSNLinking>0148-639X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005006" MajorTopicYN="N">Ethnicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">epidemiology</Keyword><Keyword MajorTopicYN="N">prognostic factors</Keyword><Keyword MajorTopicYN="N">retrospective cohort study</Keyword><Keyword MajorTopicYN="N">survival analysis</Keyword></KeywordList><CoiStatement>Disclosure of Conflicts of Interest. Mai Yamakawa &#x2013; reports no competing of interests. Sally Dwyer &#x2013; The ALS Association is a not-for-profit, voluntary health organization, exempt, together with its affiliated chapters, from federal income taxes under Section 501(c)(3) of the Internal Revenue Code (the Code). The Association and its chapters are classified collectively as a publicly supported charitable organization under section 509(a)(1) and qualify for the maximum charitable contribution deduction by donors under Section 170 (b)(1)(A)(vi) of the Code. Xing Song &#x2013; receives grant funding from the National Institutes of Health, P; and is a consultant with Dr. Mei Liu&#x2019;s NIH R01 grant at the University of Kansas Medical Center. Jeffrey Statland &#x2013; receives grant funding from the National Institutes of Health, the Muscular Dystrophy Association, the FSHD Society, and Friends of FSH Research; and is a consultant or serves on advisory boards for Fulcrum, Dyne, Avidity, Acceleron, MT Pharma, and Sarepta.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34708421</ArticleId><ArticleId IdType="mid">NIHMS1751829</ArticleId><ArticleId IdType="pmc">PMC8849587</ArticleId><ArticleId IdType="doi">10.1002/mus.27450</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, et al. Amyotrophic lateral sclerosis. Lancet (London, England) 2017; 390:2084&#x2013;2098. Published online: November 2017. DOI: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot K Motor neuron disease. Practical Neurology 2009; 9:303&#x2013;309. Published online: 2009. DOI: 10.1136/jnnp.2009.188151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.188151</ArticleId><ArticleId IdType="pubmed">19762894</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng H-JJ, Debray TPAA, Visser AE, van Eijk RPAA, Rooney JPKK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. The Lancet Neurology 2018; 17:423&#x2013;433. Published online: May 2018. DOI: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, Kaye W, Raymond J, Punjani R, Larson T, Cohen J. Prevalence of Amyotrophic Lateral Sclerosis &#x2014; United States, 2015 2018; 67. Published online: 2018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289079</ArticleId><ArticleId IdType="pubmed">30462626</ArticleId></ArticleIdList></Reference><Reference><Citation>Antao VC, Horton DK. The National Amyotrophic Lateral Sclerosis (ALS) Registry. Journal of environmental health 2012; 75:28&#x2013;30. Published online: 2012.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4549968</ArticleId><ArticleId IdType="pubmed">22866401</ArticleId></ArticleIdList></Reference><Reference><Citation>Raymond J, Oskarsson B, Mehta P, Horton K. Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010&#x2013;2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2019; 20:413&#x2013;420. Published online: 2019. DOI: 10.1080/21678421.2019.1612435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1612435</ArticleId><ArticleId IdType="pmc">PMC6946020</ArticleId><ArticleId IdType="pubmed">31131638</ArticleId></ArticleIdList></Reference><Reference><Citation>Harper CJ, Sorenson EJ, Mandrekar J. Epidemiology of amyotrophic lateral sclerosis in Minnesota: a year-long population based study. Amyotrophic lateral sclerosis &amp; frontotemporal degeneration 2015; 16:520&#x2013;523. Published online: 2015. DOI: 10.3109/21678421.2015.1051991.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1051991</ArticleId><ArticleId IdType="pubmed">26083871</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateen FJ, Carone M, Sorenson EJ. Patients who survive 5 years or more with ALS in Olmsted County, 1925&#x2013;2004. Journal of neurology, neurosurgery, and psychiatry 2010; 81:1144&#x2013;1146. Published online: October 2010. DOI: 10.1136/jnnp.2009.201251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.201251</ArticleId><ArticleId IdType="pmc">PMC2946435</ArticleId><ArticleId IdType="pubmed">20627966</ArticleId></ArticleIdList></Reference><Reference><Citation>Turabelidze G, Zhu BP, Schootman M, Malone JL, Horowitz S, Weidinger J, et al. An epidemiologic investigation of amyotrophic lateral sclerosis in Jefferson County, Missouri, 1998&#x2013;2002. NeuroToxicology 2008; 29:81&#x2013;86. Published online: 2008. DOI: 10.1016/j.neuro.2007.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2007.09.003</ArticleId><ArticleId IdType="pubmed">17950889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorenson EJ, Stalker AP, Kurland LT, Windebank AJ. Amyotrophic lateral sclerosis in Olmsted County, Minnesota, 1925 to 1998 [5] (multiple letters). Neurology 2003; 60:1560&#x2013;1561. Published online: 2003. DOI: 10.1212/WNL.60.9.1560.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.60.9.1560</ArticleId><ArticleId IdType="pubmed">12743264</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JA, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. Journal of clinical epidemiology 1989; 42:569&#x2013;575. Published online: 1989. DOI: 10.1016/0895-4356(89)90153-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(89)90153-4</ArticleId><ArticleId IdType="pubmed">2738617</ArticleId></ArticleIdList></Reference><Reference><Citation>Punjani R, Wagner L, Horton K, Kaye W. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009&#x2013;2011 and survival characteristics through 2015. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 2020; 21:123&#x2013;130. Published online: 2020. DOI: 10.1080/21678421.2019.1682614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1682614</ArticleId><ArticleId IdType="pmc">PMC8130365</ArticleId><ArticleId IdType="pubmed">31795746</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond L, Bowen G, Mertens B, Denson K, Jordan K, Vidakovic B, et al. Associations of patient mood, modulators of quality of life, and pharmaceuticals with amyotrophic lateral sclerosis survival duration. Behavioral Sciences 2020; 10:1&#x2013;20. Published online: 2020. DOI: 10.3390/bs10010033.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/bs10010033</ArticleId><ArticleId IdType="pmc">PMC7016647</ArticleId><ArticleId IdType="pubmed">31936812</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Effects of demographic factors on survival time after a diagnosis of amyotrophic lateral sclerosis. Neuroepidemiology 2015; 44:114&#x2013;120. Published online: 2015. DOI: 10.1159/000380855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000380855</ArticleId><ArticleId IdType="pmc">PMC4533862</ArticleId><ArticleId IdType="pubmed">25792423</ArticleId></ArticleIdList></Reference><Reference><Citation>Jordan H, Fagliano J, Rechtman L, Lefkowitz D, Kaye W. Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009&#x2013;2011. Neuroepidemiology 2014; 43:49&#x2013;56. Published online: 2014. DOI: 10.1159/000365850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000365850</ArticleId><ArticleId IdType="pmc">PMC4552177</ArticleId><ArticleId IdType="pubmed">25323440</ArticleId></ArticleIdList></Reference><Reference><Citation>Traxinger K, Kelly C, Johnson BA, Lyles RH, Glass JD. Prognosis and epidemiology of amyotrophic lateral sclerosis: Analysis of a clinic population, 1997&#x2013;2011. Neurology. Clinical practice 2013; 3:313&#x2013;320. Published online: August 2013. DOI: 10.1212/CPJ.0b013e3182a1b8ab.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.0b013e3182a1b8ab</ArticleId><ArticleId IdType="pmc">PMC3787117</ArticleId><ArticleId IdType="pubmed">24195020</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Aguila MA, Longstreth WT, McGuire V, Koepsell TD, Van Belle G. Prognosis in amyotrophic lateral sclerosis: A population-based study. Neurology 2003; 60:813&#x2013;819. Published online: 2003. DOI: 10.1212/01.WNL.0000049472.47709.3B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000049472.47709.3B</ArticleId><ArticleId IdType="pubmed">12629239</ArticleId></ArticleIdList></Reference><Reference><Citation>Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population validation of a scoring system and a model for survival prediction. Brain 1995; 118:707&#x2013;719. Published online: 1995. DOI: 10.1093/brain/118.3.707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/118.3.707</ArticleId><ArticleId IdType="pubmed">7600088</ArticleId></ArticleIdList></Reference><Reference><Citation>Winhammar JMC, Rowe DB, Henderson RD, Kiernan MC. Assessment of disease progression in motor neuron disease. The Lancet. Neurology 2005; 4:229&#x2013;238. Published online: April 2005. DOI: 10.1016/S1474-4422(05)70042-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(05)70042-9</ArticleId><ArticleId IdType="pubmed">15778102</ArticleId></ArticleIdList></Reference><Reference><Citation>Song X. No Title.   https://github.com/sxinger/Simulations/blob/main/simulate_survival.R.</Citation></Reference><Reference><Citation>Karanevich AG, Weisbrod LJ, Jawdat O, Barohn RJ, Gajewski BJ, He J, et al. Using automated electronic medical record data extraction to model ALS survival and progression. BMC neurology 2018; 18:205. Published online: December 2018. DOI: 10.1186/s12883-018-1208-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-018-1208-z</ArticleId><ArticleId IdType="pmc">PMC6295028</ArticleId><ArticleId IdType="pubmed">30547800</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Ludolph AC. Non-invasive ventilation in amyotrophic lateral sclerosis. Therapeutic advances in neurological disorders 2019; 12:1756286419857040. Published online: 2019. DOI: 10.1177/1756286419857040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1756286419857040</ArticleId><ArticleId IdType="pmc">PMC6589990</ArticleId><ArticleId IdType="pubmed">31258624</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A, Fini N, Ferraro D, Ferri L, Vinceti M, Mandrioli J. Percutaneous endoscopic gastrostomy, body weight loss and survival in amyotrophic lateral sclerosis: a population-based registry study. Amyotrophic lateral sclerosis &amp; frontotemporal degeneration 2017; 18:233&#x2013;242. Published online: May 2017. DOI: 10.1080/21678421.2016.1270325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1270325</ArticleId><ArticleId IdType="pubmed">28076984</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmore SE, Kasarskis EJ, Manca ML, Olney RK. Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews 2006. Published online: 2006. DOI: 10.1002/14651858.CD004030.pub2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.CD004030.pub2</ArticleId><ArticleId IdType="pubmed">17054194</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2009; 73:1218&#x2013;1226. Published online: October 2009. DOI: 10.1212/WNL.0b013e3181bc0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc0141</ArticleId><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Paipa AJ, Povedano M, Barcelo A, Dom&#xed;nguez R, Saez M, Turon J, et al. Survival benefit of multidisciplinary care in amyotrophic lateral sclerosis in spain: Association with noninvasive mechanical ventilation. Journal of Multidisciplinary Healthcare 2019; 12:465&#x2013;470. Published online: 2019. DOI: 10.2147/JMDH.S205313.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JMDH.S205313</ArticleId><ArticleId IdType="pmc">PMC6590410</ArticleId><ArticleId IdType="pubmed">31354285</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. Journal of neurology, neurosurgery, and psychiatry 2015; 86:496&#x2013;501. Published online: May 2015. DOI: 10.1136/jnnp-2014-309601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309601</ArticleId><ArticleId IdType="pubmed">25550416</ArticleId></ArticleIdList></Reference><Reference><Citation>Sukockiene E, Iancu FR, Truffert A, H&#xe9;ritier BAC, Genton L, Viatte V, et al. Multidisciplinary care in amyotrophic lateral sclerosis: A 4-year longitudinal observational study. Swiss Medical Weekly 2020; 150. Published online: 2020. DOI: 10.4414/smw.2020.20258.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2020.20258</ArticleId><ArticleId IdType="pubmed">32579697</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappella M, Ciotti C, Cohen-Tannoudji M, Biferi MG. Gene Therapy for ALS-A Perspective. International journal of molecular sciences 2019; 20. Published online: September 2019. DOI: 10.3390/ijms20184388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20184388</ArticleId><ArticleId IdType="pmc">PMC6771059</ArticleId><ArticleId IdType="pubmed">31500113</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryan L, Kaye W, Antao V, Mehta P, Muravov O, Horton DK. Preliminary results of national Amyotrophic Lateral Sclerosis (ALS) registry risk factor survey data. PLoS ONE 2016; 11:1&#x2013;18. Published online: 2016. DOI: 10.1371/journal.pone.0153683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0153683</ArticleId><ArticleId IdType="pmc">PMC4849726</ArticleId><ArticleId IdType="pubmed">27124833</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. Census Bureau (2019). American Community Survey 1-Year Estimates. Retrieved from Census Reporter Profile Page for Midwest Region
http://censusreporter.org/profiles/02000US2-midwest-region/.</Citation></Reference><Reference><Citation>Tai H, Cui L, Shen D, Li D, Cui B, Fang J. Military service and the risk of amyotrophic lateral sclerosis: A meta-analysis. Journal of Clinical Neuroscience 2017; 45:337&#x2013;342. Published online: 2017. DOI: 10.1016/j.jocn.2017.08.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2017.08.035</ArticleId><ArticleId IdType="pubmed">28864407</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang MD, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology 2017; 61:101&#x2013;130. Published online: 2017. DOI: 10.1016/j.neuro.2016.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId><ArticleId IdType="pubmed">27377857</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay KA, Smith KA, Smertinaite L, Fang F, Ingre C, Taube F. Military service and related risk factors for amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 2020:1&#x2013;12. Published online: 2020. DOI: 10.1111/ane.13345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13345</ArticleId><ArticleId IdType="pmc">PMC7756624</ArticleId><ArticleId IdType="pubmed">32905613</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg JJ, Johnson NJ, Weisskopf MG. Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort: Extended Follow-up 1979&#x2013;2011. Epidemiology (Cambridge, Mass.) 2017; 28:e15&#x2013;e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5285394</ArticleId><ArticleId IdType="pubmed">27893489</ArticleId></ArticleIdList></Reference><Reference><Citation>Haley RW. Excess incidence of ALS in young Gulf War veterans. Neurology 2003; 61:750&#x2013;756. Published online: September 2003. DOI: 10.1212/wnl.61.6.750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.61.6.750</ArticleId><ArticleId IdType="pubmed">14504316</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, et al. Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology 2003; 61:742&#x2013;749. Published online: September 2003. DOI: 10.1212/01.wnl.0000069922.32557.ca.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000069922.32557.ca</ArticleId><ArticleId IdType="pubmed">14504315</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf MG, Cudkowicz ME, Johnson N. Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort. Epidemiology (Cambridge, Mass.) 2015; 26:831&#x2013;838. Published online: November 2015. DOI: 10.1097/EDE.0000000000000376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0000000000000376</ArticleId><ArticleId IdType="pmc">PMC4604116</ArticleId><ArticleId IdType="pubmed">26414854</ArticleId></ArticleIdList></Reference><Reference><Citation>Horner RD, Grambow SC, Coffman CJ, Lindquist JH, Oddone EZ, Allen KD, et al. Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak. Neuroepidemiology 2008; 31:28&#x2013;32. Published online: 2008. DOI: 10.1159/000136648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000136648</ArticleId><ArticleId IdType="pubmed">18535397</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth SK, Kang HK, Bullman TA, Wallin MT. Neurological mortality among U.S. veterans of the Persian Gulf War: 13-year follow-up. American journal of industrial medicine 2009; 52:663&#x2013;670. Published online: September 2009. DOI: 10.1002/ajim.20718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajim.20718</ArticleId><ArticleId IdType="pubmed">19585544</ArticleId></ArticleIdList></Reference><Reference><Citation>Seals RM, Hansen J, Gredal O, Weisskopf MG. Physical Trauma and Amyotrophic Lateral Sclerosis: A Population-Based Study Using Danish National Registries. American journal of epidemiology 2016; 183:294&#x2013;301. Published online: February 2016. DOI: 10.1093/aje/kwv169.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwv169</ArticleId><ArticleId IdType="pmc">PMC4753279</ArticleId><ArticleId IdType="pubmed">26825926</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>